Star Cement (540575) Q4 17/18 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 17/18 earnings summary
19 Oct, 2026Executive summary
Record FY2017-18 profits: consolidated revenue from operations ₹1,633.49 crore and EBITDA ₹525.73 crore; PAT rose 70% YoY.
Prioritised realisations and logistics savings over volume, consolidating sales in North East, North Bengal and East Bihar while exiting Jharkhand and reducing exposure in West Bihar and South Bengal.
Used subsidy receipts to repay debt, targeting a debt-free position in FY2018-19; announced capacity growth led by a proposed 2 MTPA Siliguri grinding plant.
Financial highlights
Consolidated net sales ₹1,633.49 crore vs ₹1,554.27 crore in FY2016-17; EBITDA ₹525.73 crore vs ₹410.77 crore.
Consolidated PBT ₹352.59 crore vs ₹214.80 crore; PAT ₹336.18 crore vs ₹200.90 crore.
FY2017-18 headline metrics: EBITDA margin 32.73%, PAT margin 20.58%, cash profit ₹457 crore.
Consolidated EPS ₹7.89 vs ₹4.64; proposed final dividend ₹1 per equity share.
Outlook and guidance
Targeted 15% volume growth in FY2018-19 through deeper market penetration and higher utilisation without compromising brand positioning.
Proposed 2 MTPA Siliguri grinding plant targeted for commissioning in FY2019-20; planned Meghalaya clinker debottlenecking to supply it.
Longer-term ambition: 10 MTPA capacity by 2022, including a further equivalent plant in Durgapur or Bihar after Siliguri.
Expected to become debt-free in FY2018-19; Siliguri expansion intended to be funded largely from internal accruals with minimal debt.
Latest events from Star Cement
- Revenue rose, consolidated profit fell, and the ₹1,500 crore fund raise was deferred.540575
Q2 26/27 - Record FY10 earnings and expansion plans face rising input-cost pressure.540575
Q4 09/10 - Record output and expansion plans countered cost pressure and softer consolidated profits.540575
Q4 10/11 - Volume gains and expansion advanced despite falling profits and surging costs.540575
Q4 11/12 - New capacity and market expansion plans amid sharply lower profit and rising costs.540575
Q4 12/13 - New capacity drove rapid growth, but higher financing and depreciation costs kept FY14 in loss.540575
Q4 13/14 - Sales volume rose 33% and EBITDA 85% as capacity expansion drove growth.540575
Q4 14/15 - Volumes and revenue grew, but lower realizations and higher costs cut EBITDA.540575
Q4 15/16 - Profit rose despite a weak market, while regional sales and capacity expansion advanced.540575
Q4 16/17